Male Hair Loss Dataset - 2 400+ images

Dataset comprises medical images of scalps from five angles, labeled with seven classifications based on the Norwood-Hamilton scale, aiding in diagnosing hair losses and scalp conditions. Utilizing deep learning techniques, machine learning algorithms can analyze hair density, follicles, and hair growth patterns to improve accurate diagnosis of alopecia areata and other hair disorders. — Get the data

  Dataset characteristics:… See the full description on the dataset page: https://huggingface.co/datasets/ud-medical/male-hair-loss-dataset.

Bald Men Dataset

Dataset comprises 3,100 images from 775 individuals, featuring male alopecia cases captured from two angles (front + top views) with corresponding segmentation masks. Designed for machine learning and deep learning models, this collection supports research in hair follicles analysis, hair density measurement, and scalp health evaluation. By leveraging this dataset, researchers can improve learning algorithms for detecting hair disorders, evaluating hair restoration… See the full description on the dataset page: https://huggingface.co/datasets/UniDataPro/men-hair-loss-dataset.

Male Hair Loss Dataset with annotated images for training AI in male pattern baldness classification, dermatology research

Bald Men Dataset

Dataset comprises 3,100 images from 775 individuals, featuring male alopecia cases captured from two angles (front + top views) with corresponding segmentation masks. Designed for machine learning and deep learning models, this collection supports research in hair follicles analysis, hair density measurement, and scalp health evaluation.

By leveraging this dataset, researchers can improve learning algorithms for detecting hair disorders, evaluating hair restoration techniques, and training models for early diagnosis of alopecia. - Get the data

The inclusion of segmentation masks ensures accurate classification of hair textures, scalp conditions, and hair growth stages, making it invaluable for medical image analysis and AI-driven dermatology.

💵 Buy the Dataset: This is a limited preview of the data. To access the full dataset, please contact us at https://unidata.pro to discuss your requirements and pricing options.

Example for the dataset

https://www.googleapis.com/download/storage/v1/b/kaggle-user-content/o/inbox%2F27063537%2F94b27bc05225cb65e752c8df15803d84%2FFrame%203%20(1).png?generation=1751972352481372&alt=media" alt=""> Each participant contributes 4 images (original + mask pairs), enabling precise diagnosis of hair loss, hair thinning patterns, and treatment personalization.

🌐 UniData provides high-quality datasets, content moderation, data collection and annotation for your AI/ML projects

Male Hair Loss Dataset - 2 400+ images

Dataset comprises 2,400+ photos of male alopecia (hair loss) captured from 5 angles, meticulously labeled into 7 classes according to the Norwood-Hamilton scale. It is designed for machine learning and deep learning applications, particularly in diagnosing hair disorders, evaluating scalp health, and personalizing hair restoration treatments. By utilizing this dataset, researchers and dermatologists can enhance hair loss analysis, improve… See the full description on the dataset page: https://huggingface.co/datasets/UniDataPro/hair-loss-male-norwood-scale.

Men hair loss dataset for computer vision. Our data includes perfect segmentation and Norwood scale classification to train a robust AI model

The men's hair loss prevention and growth product market is experiencing robust growth, driven by increasing awareness of hair loss solutions and a rising demand for effective treatments among a growing male population concerned about their appearance. While precise market size figures are not provided, considering the presence of major players like Procter & Gamble, L'Oreal, and Unilever, alongside numerous niche brands, and referencing industry reports suggesting similar markets reach billions in value, a reasonable estimate for the 2025 market size would be $5 billion. The Compound Annual Growth Rate (CAGR) is crucial; let's assume a conservative CAGR of 6% for the forecast period (2025-2033), based on historical growth trends in related personal care categories and ongoing innovation within the hair loss treatment space. This CAGR reflects both market expansion driven by product innovation and a continued increase in consumer awareness and adoption. Key market drivers include the rising prevalence of androgenetic alopecia (male pattern baldness), increased disposable income allowing men to invest in premium hair care products, and growing acceptance of hair loss treatments among younger demographics. However, market restraints include potential side effects associated with certain treatments, high product costs, and the availability of less expensive, albeit potentially less effective, alternatives. Market segmentation spans various product types (topical treatments, oral medications, hair transplant services, etc.), distribution channels (e-commerce, brick-and-mortar retailers, dermatology clinics), and price points, offering diverse opportunities for both established and emerging players. The market's future trajectory is highly promising, with innovation playing a pivotal role. We can anticipate further development in more effective, less invasive treatments, along with targeted marketing campaigns tailored to specific demographics and consumer preferences. This could lead to an expansion of the market beyond its current parameters, even exceeding the projected CAGR. Growing consumer demand for natural and organic ingredients, alongside greater transparency and stricter regulation, will shape the market's evolution. The continued competition among established and emerging players necessitates a strong focus on research and development, targeted marketing strategies, and strategic partnerships to secure market share within this expanding and dynamic sector. This competitive landscape ensures continuous improvement in both product effectiveness and consumer experience, driving sustained growth throughout the forecast period.

The global market for men's hair loss treatment is a substantial and rapidly growing sector, projected to reach $200.3 million in 2025. A compound annual growth rate (CAGR) of 4.3% from 2025 to 2033 indicates a promising outlook, driven by several key factors. Increased awareness of hair loss solutions, coupled with rising disposable incomes and a growing preference for aesthetic treatments among men, are significant contributors to this growth. The market is segmented by product type (topical solutions, oral medications, surgical procedures, and hair transplants), distribution channel (pharmacies, online retailers, dermatology clinics), and geographic region. Major players like Procter & Gamble, L'Oréal, and Unilever dominate the market, leveraging their extensive distribution networks and established brands. However, emerging companies specializing in innovative treatments and niche products are also gaining traction, creating a dynamic competitive landscape. The increasing prevalence of androgenetic alopecia (male pattern baldness) is a primary driver, fueling demand for both pharmaceutical and cosmetic solutions. Furthermore, advancements in hair transplantation techniques and the development of more effective topical treatments are contributing to market expansion. While the market demonstrates strong growth potential, certain restraints exist. High treatment costs, particularly for surgical procedures like hair transplants, can limit accessibility for a significant portion of the population. Concerns regarding potential side effects associated with certain medications also influence consumer choices. The market's success hinges on continued innovation to develop safer, more effective, and cost-effective solutions. Effective marketing and education campaigns aimed at raising awareness about available options and dispelling misconceptions are also crucial for further growth. The continued expansion of e-commerce platforms offers opportunities for market penetration and access to a broader consumer base. Future market success will be contingent upon successful navigation of regulatory hurdles and the development of personalized treatment plans tailored to individual needs.

Male pattern baldness can have substantial psychosocial effects, and it has been phenotypically linked to adverse health outcomes such as prostate cancer and cardiovascular disease. We explored the genetic architecture of the trait using data from over 52,000 male participants of UK Biobank, aged 40–69 years. We identified over 250 independent genetic loci associated with severe hair loss (P

The global market for men's hair loss prevention and growth stimulation products is experiencing robust growth, driven by increasing awareness of hair loss solutions and a rising demand for effective treatments among men of all ages. The market is segmented by application (supermarkets, e-commerce, other) and product type (essential oils, shampoos, other). While precise market sizing data wasn't provided, considering the presence of major players like Procter & Gamble, L'Oreal, and Unilever, and the significant investment in research and development within this sector, a conservative estimate of the 2025 market size could be placed at $15 billion USD. A compounded annual growth rate (CAGR) of 5-7% is plausible for the forecast period (2025-2033), reflecting continued innovation in product formulations and the expansion of distribution channels. Key drivers include the increasing prevalence of androgenetic alopecia (male pattern baldness), growing disposable incomes, particularly in developing economies, and increased marketing and promotion of these products. However, potential restraints include the high cost of some treatments, varying efficacy among different products, and potential side effects associated with certain ingredients. The e-commerce channel is expected to show significant growth, capitalizing on convenience and broader reach. The substantial presence of established companies coupled with the entry of niche players and the exploration of natural ingredients signals a dynamic and competitive market landscape. The North American market is expected to maintain a dominant position, followed by Europe and Asia-Pacific, mirroring existing consumer trends and economic conditions in these regions. Competitive intensity is high, with both established multinational corporations and smaller, specialized companies vying for market share. Successful players are focusing on research and development to create innovative products, personalized solutions, and effective marketing strategies that target specific demographic segments within the male population. Future growth will likely be propelled by technological advancements in hair loss treatments, personalized medicine approaches, and increased consumer awareness and acceptance of non-invasive hair restoration techniques. Market segmentation by product type will see continued expansion, with an anticipated increase in demand for natural and organic products reflecting broader consumer preferences for healthier and sustainable options.

United States Men’s Hair Loss Prevention Growth Products Market was valued at USD 314.56 Million in 2024 and is expected to reach USD 657.89 Million by 2030 with a CAGR of 5.34%.

Snapshot img

Hair Loss Treatment Products Market Size 2024-2028

The hair loss treatment products market is estimated to grow by USD 2.52 billion at a CAGR of 4.96% between 2023 and 2028. The market is experiencing momentum due to escalating consumer concerns regarding hair-related issues. Innovative advancements in product development and expansions in product portfolios are leading to premiumization, appealing strongly to consumers who seek reliable and effective solutions. Additionally, heightened awareness about hair care is contributing to increased demand for hair products, driving substantial growth in the market as individuals prioritize addressing these specific concerns. This trend underscores a shift towards more personalized and targeted solutions in the hair care sector, where products are not only functional but also cater to the evolving needs and preferences of consumers. As a result, manufacturers are increasingly focusing on research and development to meet these demands, thereby shaping the competitive landscape of the market.

What will be the size of the Market During the Forecast Period?

To learn more about this report, Download Report Sample

Market Segmentation

By Product Type

The market share growth by the vitamins and supplements segment will be significant during the forecast period. The adoption of vitamins and supplements in the market is high due to factors such as rising awareness and consumption of these hair care products and the increasing demand from developing countries.

Get a glance at the market contribution of various segments Request a PDF Sample

The vitamins and supplements segment was valued at USD 3.28 billion in 2018. Vitamins and supplements are great for the overall health of the hair and boost hair growth significantly. Vitamins fight frizz, tame flyaways, and protect against heat damage caused by styling tools. Meanwhile, supplements such as iron, biotin, zinc, selenium, and folic acid improve hair health and growth. Such factors are driving the growth of the vitamins and supplements segment in the market during the forecast period.

By Region

For more insights on the market share of various regions Request PDF Sample now!

APAC is estimated to contribute 41% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. Countries such as China, Japan, and India are the major revenue contributors in APAC. This is due to the changing climate in various regions of APAC, which is an environmental factor causing people to suffer from hair damage and hair loss-related issues. Major manufacturers such as Unilever PLC and L'Oreal SA have been introducing innovative and enhanced hair loss treatment products every year, which are affordable and easily available in all supermarkets and hypermarkets in developed as well as developing countries. Moreover, the growing trend of online shopping is contributing to the growth of the market in APAC. Hair loss treatment products are often complemented by hair wigs and extensions, providing both medical and cosmetic solutions for individuals experiencing hair thinning or loss. In developing markets, e-commerce companies offer discounts on almost every product to increase the volume of sales of personal care products, including hair loss treatment products.

Market Dynamics and Customer Landscape

The market encompasses a wide range of offerings designed to address various types of hair loss, including hormonal imbalance-related baldness, androgenetic alopecia, alopecia areata, and chemotherapy-induced hair loss. Factors contributing to the growth of this market include stress, environmental pollution, major diseases, aging, and lifestyle. Hormonal imbalance, particularly in males and females, is a significant cause of hair loss. Medications, shampoos, conditioners, serums, and hair care products are the primary hair loss treatment product categories. TV commercials have played a significant role in emphasizing the importance of addressing hair loss, driving demand for these products. Stress level and lifestyle choices also impact hair health, making stress management and self-care essential. Cosmetic clinics are increasingly recommending hair fall control products from Plenty Natural to effectively address male hair loss and promote healthier hair growth. Oral supplements, laser therapy, scalp injections, and hair transplant surgeries are other popular hair loss treatment options. Male and female hair loss, as well as baldness, are common concerns addressed by these treatments. Aging and major diseases, such as alopecia areata, also contribute to the market's growth. The dermatology industry plays a crucial role in diagnosing and treating hair loss conditions, further bolstering market demand.

Key Market Driver

The market experiences notable growth due

The global hair loss treatment market is projected to be valued at $14.8 billion in 2024, driven by factors such as increasing consumer awareness and the rising prevalence of industry-specific trends. The market is expected to grow at a CAGR of 7.4%, reaching approximately $29.4 billion by 2034.

The global anti-hair loss medicine market is experiencing robust growth, driven by increasing awareness of hair loss treatments, rising prevalence of androgenetic alopecia (male and female pattern baldness), and the growing popularity of non-invasive hair restoration solutions. The market, estimated at $10 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 6% from 2025 to 2033, reaching approximately $15 billion by 2033. This expansion is fueled by several key factors. Technological advancements leading to more effective and convenient treatments, such as topical solutions and oral medications, are significantly contributing to market growth. Furthermore, the increasing disposable income in developing economies, coupled with a rising demand for aesthetic treatments, is driving higher adoption rates. The segment encompassing topical hair growth liquids currently holds the largest market share, reflecting consumer preference for less invasive treatment options. However, the tablet segment is witnessing significant growth due to its ease of administration and efficacy. Key players like Giuliani, Bayer AG, Regaine, Pfizer, and Hims & Hers Health are actively investing in research and development to introduce innovative products and expand their market presence, fueling competition and innovation within the market. Geographic distribution shows North America and Europe currently dominate the market, but significant growth opportunities are expected in the Asia-Pacific region, driven by a burgeoning middle class and increased awareness of hair loss treatments. The market faces certain restraints, including high treatment costs, potential side effects of certain medications, and the time-consuming nature of some therapies. However, ongoing research and development efforts focusing on minimizing side effects and improving treatment efficacy are expected to mitigate these challenges. The market is segmented by application (pharmacy, hospital) and type (hair growth liquid, tablet, others). The competitive landscape is characterized by the presence of both established pharmaceutical companies and emerging players, creating a dynamic market with ongoing innovation and product differentiation. The continued focus on personalized medicine and targeted therapies promises further growth in the years ahead, making anti-hair loss medication a continuously evolving and expanding market sector.

According to a survey among South Korean men on hair loss treatment options in 2022, around **** percent of surveyed men stated that they were using hair loss shampoo. That year, around **** percent of men stated the were "very worried" about hair loss.

Overview

New York, NY – June 23, 2025 – Global Androgenetic Alopecia Market size is expected to be worth around US$ 6.7 billion by 2034 from US$ 3.0 Billion in 2024, growing at a CAGR of 8.4% during the forecast period 2025 to 2034. In 2024, North America led the market, achieving over 38.4% share with a revenue of US$ 1.2 Billion.

The global androgenetic alopecia market is experiencing steady growth, driven by the increasing prevalence of hair loss among both men and women, particularly those aged 30 and above. Androgenetic alopecia, also known as male-pattern or female-pattern baldness, is the most common form of progressive hair loss caused by genetic and hormonal factors. It affects over 50% of men and nearly 40% of women by the age of 50, according to data from leading public health agencies.

The market is segmented based on treatment type, gender, and end-user. Pharmacological treatments such as topical minoxidil and oral finasteride remain the primary options, while demand for advanced therapies like platelet-rich plasma (PRP), low-level laser therapy (LLLT), and stem cell-based interventions continues to grow. In 2023, male patients accounted for a dominant share, but awareness and diagnosis among female patients are increasing rapidly.

Clinics specializing in dermatology and aesthetic medicine represent the largest end-user segment, benefiting from the rising number of outpatient consultations for hair restoration. North America holds a significant share due to better diagnosis rates, treatment availability, and consumer awareness. However, Asia-Pacific is expected to witness the highest growth rate, supported by a growing youth population, urbanization, and rising cosmetic consciousness.

Hair Loss Treatment for Men Market Outlook

The global hair loss treatment for men market size was valued at approximately $4.2 billion in 2023 and is expected to reach around $6.8 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period. The growth of this market is driven by various factors, including an increasing awareness about hair loss treatments, rising disposable incomes, and advancements in medical technology. Furthermore, the societal pressures and the importance placed on physical appearance, particularly for men in professional settings, have significantly contributed to the increasing demand for effective hair loss treatments.

One of the primary growth factors for the hair loss treatment market is the growing awareness and acceptance of cosmetic procedures among men. Over the past decade, there has been a noticeable shift in societal attitudes towards male grooming and aesthetics. Men are now more open to seeking treatments for conditions that affect their appearance, such as hair loss. This change is partly driven by the influence of media and celebrities, who openly discuss and endorse hair restoration procedures. Additionally, the availability of information on various treatments through online platforms has empowered men to make informed decisions about their hair care.

Advancements in medical technology and treatment options have also fueled market growth. Innovations such as laser therapy, platelet-rich plasma (PRP) therapy, and improved hair transplant techniques have made hair restoration more effective and accessible. These advancements have reduced the downtime and side effects associated with traditional treatments, making them more appealing to potential patients. Moreover, ongoing research and development in the field of trichology are expected to introduce new and improved treatments, further driving the market's expansion.

Economic factors, such as increasing disposable incomes and higher spending on personal care, particularly in emerging markets, have played a crucial role in the market's growth. As middle-class populations expand in countries like China, India, and Brazil, there is a growing willingness to invest in personal grooming and aesthetic treatments. This trend is supported by the proliferation of clinics and treatment centers offering specialized hair loss treatments, making them more accessible to a broader demographic. Additionally, the growing health and wellness trend, emphasizing self-care and physical appearance, has contributed to the market's upward trajectory.

On a regional level, North America and Europe are currently the largest markets for hair loss treatments for men, driven by high awareness and acceptance of cosmetic procedures, advanced healthcare infrastructure, and significant spending power. However, the Asia Pacific region is expected to witness the fastest growth during the forecast period, with a CAGR of 6.0%. This growth can be attributed to the increasing population, rising disposable incomes, and growing awareness of hair loss treatments. Moreover, the expanding middle class in countries like China and India is expected to drive demand for these treatments significantly.

Treatment Type Analysis

The hair loss treatment market for men is segmented by treatment types, including medications, hair transplant procedures, laser therapy, platelet-rich plasma (PRP) therapy, and others. Each treatment type offers unique benefits and caters to different needs and preferences, making this segment a diverse and dynamic part of the market.

Medications, including topical treatments like minoxidil and oral drugs like finasteride, form a substantial part of the market. These treatments are generally the first line of defense against hair loss due to their non-invasive nature and ease of use. Minoxidil, for example, has been widely used for decades and is known for its effectiveness in promoting hair growth. Finasteride, on the other hand, works by inhibiting the hormone responsible for hair loss in men. The convenience of these treatments, coupled with their affordability, has made them a popular choice among men experiencing early stages of hair loss.

Finasteride has emerged as a cornerstone in the pharmacological approach to managing male pattern baldness, a common form of hair loss in men. This oral medication works by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), a hormone linked

Androgenetic alopecia (“AGA”) is the most prevalent type of progressive hair loss, causing tremendous psychological and social stress in patients. However, AGA treatment remains limited in scope. The pathogenesis of androgenetic alopecia is not completely understood but is known to involve a hair follicle miniaturization process in which terminal hair is transformed into thinner, softer vellus-like hair. This process is related to the dysregulation of the Wnt/β-catenin signaling pathway, which causes premature termination of the anagen growth phase in hair follicles. Historically used for wound healing, platelet rich plasma (“PRP”) has recently been at the forefront of potential AGA treatment. PRP is an autologous preparation of plasma that contains a high number of platelets and their associated growth factors such as EGF, IGF-1, and VEGF. These factors are known to individually play important roles in regulating hair follicle growth. However, the clinical effectiveness of PRP is often difficult to characterize and summarize as there are wide variabilities in the PRP preparation and administration protocols with no consensus on which protocol provides the best results. This study follows the previous review from our group in 2018 by Cervantes et al. to analyze and discuss recent clinical trials using PRP for the treatment of AGA. In contrast to our previous publication, we include recent clinical trials that assessed PRP in combination or in direct comparison with standard of care procedures for AGA such as topical minoxidil and/or oral finasteride. Overall, this study aims to provide an in-depth analysis of PRP in the treatment of AGA based on the evaluation of 17 recent clinical trials published between 2018 and October 2021. By closely examining the methodologies of each clinical trial included in our study, we additionally aim to provide an overall consensus on how PRP can be best utilized for the treatment of AGA.

The global laser hair loss treatment market, valued at $271.8 million in 2025, is projected to experience steady growth, driven by a compound annual growth rate (CAGR) of 3.8% from 2025 to 2033. This growth is fueled by several key factors. Increasing awareness of hair loss solutions and advancements in laser technology offering more effective and less invasive treatments are significant contributors. The rising prevalence of androgenetic alopecia (male and female pattern baldness), coupled with a growing demand for non-surgical, minimally invasive cosmetic procedures, further propels market expansion. The convenience and minimal downtime associated with laser hair loss treatments are also attractive to busy individuals seeking quick and effective solutions. Major players like Apira Science, Capillus, Eclipse Aesthetics, HairMax, iRestore, and NutraStim are actively contributing to market growth through innovation and expansion of their product portfolios. While the market exhibits strong growth potential, certain factors might act as restraints. The relatively high cost of laser hair loss treatments compared to other options can limit accessibility for certain demographics. Furthermore, inconsistent treatment efficacy across various devices and the potential for mild side effects, although rare, might influence consumer adoption. To overcome these challenges, companies are investing in research and development to improve device efficacy, affordability, and safety, making laser hair loss treatment a more viable option for a wider audience. Segmentation within the market is likely driven by device type (low-level laser therapy devices versus others), treatment setting (home-use versus clinic-based), and geographic location, reflecting varying levels of awareness and adoption rates.

The global topical hair loss treatment market is experiencing robust growth, driven by increasing awareness of hair loss solutions and a rising prevalence of androgenetic alopecia (male and female pattern baldness) across various demographics. The market, estimated at $5 billion in 2025, is projected to witness a Compound Annual Growth Rate (CAGR) of 6% from 2025 to 2033, reaching an estimated $8 billion by 2033. This expansion is fueled by several key factors. Firstly, the increasing acceptance of hair loss treatments as a legitimate healthcare concern is leading to higher adoption rates. Secondly, the market is witnessing innovation in product formulations, with a shift towards more effective and less side-effect-prone treatments like advanced minoxidil solutions and herbal extracts, catering to diverse consumer preferences. Thirdly, the expanding e-commerce landscape is providing convenient access to a wider range of products, further boosting market accessibility. Major players like Johnson & Johnson, Taisho Pharma, and Procter & Gamble are driving innovation and market penetration through strategic product launches and marketing campaigns. However, the market faces certain restraints. The high cost of some treatments can limit accessibility, particularly in developing economies. Furthermore, inconsistent efficacy across different product types and potential side effects can lead to consumer hesitancy. The segment dominated by Minoxidil solutions accounts for a significant market share, but the herbal extract treatment segment is experiencing strong growth driven by increasing consumer preference for natural alternatives. Geographical distribution shows robust growth in North America and Europe, driven by high awareness and expenditure on healthcare, but the Asia-Pacific region is expected to showcase significant growth potential in the coming years due to increasing disposable incomes and rising awareness. The market segmentation by gender shows relatively balanced demand from both male and female consumers, reflecting the broad reach of hair loss concerns.